![]() |
COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. | ![]() |
University of Cambridge > Talks.cam > Lectures in Cancer Biology and Medicine > The AKT inhibitor Capivasertib (AZD5363): from discovery to clinical proof of concept
![]() The AKT inhibitor Capivasertib (AZD5363): from discovery to clinical proof of conceptAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Justin Holt. This talk has been canceled/deleted Abstract not available This talk is part of the Lectures in Cancer Biology and Medicine series. This talk is included in these lists:This talk is not included in any other list Note that ex-directory lists are not shown. |
Other listsHomerton Changemakers Centenary Year of the Medical Research Council and International Year of Statistics Vascular Biology Research SeminarsOther talksHoles in higher Teichmuller theory Cancer stem cells, evolution and heterogeneity Statistics Clinic Summer 2022 II Statistics Clinic Lent 2022 V The launch of the online NatHistFest Sustainable Cities |